Ticker
XFORCompany Name
X4 PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -109.3M | -333.48% | $ 32.77M |
3/31/2025 | $ -109.67M | -349.67% | $ 31.36M |
12/31/2024 | $ -130.9M | -5119.32% | $ 2.56M |
9/30/2024 | $ -125.65M | -11189.05% | $ 1.12M |
6/30/2024 | $ -112.45M | -19973.18% | $ 563K |
3/31/2024 | $ -103.6M | 0% | $ 0 |
12/31/2023 | $ -96.51M | 0% | $ 0 |
9/30/2023 | $ -87.86M | 0% | $ 0 |
6/30/2023 | $ -86.34M | 0% | $ 0 |
3/31/2023 | $ -83.39M | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for X4 PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ -50.55M ] / Revenues [ $ 3M ]
(=) OCF % [ -1685.17% ]
Minimum
Jun 30, 2024
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |